T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects

Summary GAD65 is one of the major autoantigens associated with insulin-dependent diabetes mellitus (IDDM). The two peptides p17 and p18 of GAD65 that share sequence similarity with coxsackie virus (amino acid sequence identity: PEVKEK) appeared to be the major determinants of GAD65 recognized preferably by T cells from new-onset IDDM patients and their first degree relatives. In contrast, in our study unrelated control subjects frequently recognized the two GAD peptides (55 %, 16/29), similar to first degree relatives (41 %, 12/29) and IDDM patients post-onset (68 %, 15/22). However, recent-onset IDDM patients, responded less frequently (25 %, 4/16) compared with IDDM patients post-onset (p < 0.03) or unrelated control subjects (borderline significant) confirming previous observations in humans and NOD mice that T-cell reactivity to GADp17/p18 at diabetes onset is decreased. Moreover, this study demonstrated a positive correlation of T-cell proliferation to GAD p17 (amino acid 247–266) and p18 (amino acid 260–279) with simultaneous responses to both peptides in 13 % of all subjects tested (n = 97) (p < 0.001). T-cell proliferation to GAD p17 was higher than to p18 in recent-onset diabetic patients, first degree relatives and unrelated control subjects (p < 0.02, p < 0.004, p < 0.002, respectively). However, in post-onset IDDM patients, the two peptides were recognized equally well. Our results show that T-cell reactivity to GAD65 peptides homologous with coxsackie protein is very frequently observed, but not primarily associated with IDDM. The temporary decline of T-cell proliferation is not associated with the beta-cell destruction process, but with clinical manifestation. The positive correlation of reactivity to the two peptides in the viral motif implicates that PEVKEK is an immunogenic epitope. [Diabetologia (1997) 40: 332–338]

[1]  J. Lamb,et al.  Identification of two binding sites in staphylococcal enterotoxin B that confer specificity for TCR V beta gene products. , 1994, International immunology.

[2]  J. Palmer,et al.  Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.

[3]  G. Eisenbarth,et al.  Quantitation of Glutamic Acid Decarboxylase Autoantibody Levels in Prospectively Evaluated Relatives of Patients With Type I Diabetes , 1994, Diabetes.

[4]  A. Ziegler,et al.  Cellular Immune Response to Diverse Islet Cell Antigens in IDDM , 1996, Diabetes.

[5]  M. Atkinson,et al.  Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes , 1996, The Journal of experimental medicine.

[6]  H. Chase,et al.  Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. , 1996, Journal of autoimmunity.

[7]  D. R. Gamble,et al.  ISLET-CELL ANTIBODIES IN DIABETES MELLITUS , 1976, The Lancet.

[8]  M. Atkinson,et al.  The pathogenesis of insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[9]  M. Atkinson,et al.  64 000 Mr autoantibodies as predictors of insulin-dependent diabetes , 1990, The Lancet.

[10]  L. Harrison,et al.  Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes , 1993, The Lancet.

[11]  A. Tobin,et al.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes , 1993, Nature.

[12]  E. Bonifacio,et al.  Antibodies to Islet 37k Antigen, But Not to Glutamate Decarboxylase, Discriminate Rapid Progression to IDDM in Endocrine Autoimmunity , 1994, Diabetes.

[13]  G. Eisenbarth,et al.  Type I diabetes mellitus: a chronic autoimmune disease? , 1984, Pediatric clinics of North America.

[14]  S. Baekkeskov,et al.  Islet cell and 64K autoantibodies are associated with plasma IgG in newly diagnosed insulin-dependent diabetic children. , 1986, Journal of immunology.

[15]  S. Arden,et al.  T-Cell Reactivity to β-Cell Membrane Antigens Associated With β-Cell Destruction in IDDM , 1995, Diabetes.

[16]  L. J. Nell,et al.  The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics. , 1983, Journal of Immunology.

[17]  M. A. Bowman,et al.  Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. , 1994, The Journal of clinical investigation.

[18]  M. Christie,et al.  Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). , 1995, The Journal of clinical investigation.

[19]  H. Kolb,et al.  HLA‐associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent‐onset insulin‐dependent diabetes mellitus , 1996, European journal of immunology.

[20]  A. Hayek,et al.  Ontogeny and tissue distribution of human GAD expression. , 1996, Diabetes.

[21]  S. Arden,et al.  T-cell reactivity to beta-cell membrane antigens associated with beta-cell destruction in IDDM. , 1995, Diabetes.

[22]  R. Tisch,et al.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.

[23]  Bart O. Roep,et al.  T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins , 1990, Nature.

[24]  M. Atkinson,et al.  The clinical significance of an autoimmune response against glutamic acid decarboxylase , 1996, Nature Medicine.

[25]  K. Lafferty,et al.  Autoimmune Diabetes in NOD Mouse Is L3T4 T-Lymphocyte Dependent , 1987, Diabetes.

[26]  L. Harrison,et al.  Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin- dependent diabetes , 1993, The Journal of experimental medicine.

[27]  Roberto Gianani,et al.  ICA512 Autoantibody Radioassay , 1995, Diabetes.

[28]  M. Erlander,et al.  Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes , 1992, The Lancet.

[29]  P. Argos,et al.  Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. , 1984, Nucleic acids research.

[30]  M. Atkinson,et al.  Insulin autoantibodies in pre-diabetes. , 1988, Advances in experimental medicine and biology.

[31]  P. Bingley,et al.  Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives , 1994, Diabetes.

[32]  S. Baekkeskov,et al.  Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. , 1988, Diabetologia.

[33]  J. Ilonen,et al.  Cellular Immune Response to Cow's Milk β-Lactoglobulin in Patients With Newly Diagnosed IDDM , 1996, Diabetes.

[34]  M. Erlander,et al.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[35]  S. Baekkeskov,et al.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins , 1982, Nature.

[36]  R. Rajotte,et al.  T cell activation and anergy to islet cell antigen in type I diabetes. , 1995, Journal of immunology.

[37]  R. J. Keller,et al.  Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus. , 1990, Journal of autoimmunity.

[38]  M. Knip,et al.  A Prospective Study of the Role of Coxsackie B and Other Enterovirus Infections in the Pathogenesis of IDDM , 1995, Diabetes.

[39]  S. Baekkeskov,et al.  Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.